TOL Form 144 Notice: 20,145 Shares from Restricted Stock Lapse to Be Sold
Rhea-AI Filing Summary
Toll Brothers insider sale notice: This Form 144 reports a proposed sale of 20,145 shares of Toll Brothers, Inc. (NYSE: TOL) through Charles Schwab & Co., with an aggregate market value listed at $2,983,106 and an approximate sale date of 09/08/2025. The shares were acquired as a restricted stock lapse on 12/01/2024 and were granted as equity compensation. The filing also discloses a recent sale by Douglas C. Yearley Jr. of 25,000 shares on 08/29/2025 for gross proceeds of $3,456,384. The filer certifies no undisclosed material adverse information and includes the standard Rule 144 representations regarding trading plans and disclosures.
Positive
- None.
Negative
- Insider sale disclosed: Proposed sale of 20,145 shares valued at $2,983,106 (approximate sale date 09/08/2025)
- Recent related insider sale: Douglas C. Yearley Jr. sold 25,000 shares on 08/29/2025 for $3,456,384
Insights
TL;DR: Routine Rule 144 insider sale of equity compensation; size is modest and consistent with controlled disposition.
The filer intends to sell 20,145 shares acquired via a restricted stock lapse on 12/01/2024, valued at $2,983,106, through Charles Schwab with an approximate sale date of 09/08/2025. The filing is procedural and includes the required representation that no material nonpublic information is known. A separate near-term sale by Douglas C. Yearley Jr. of 25,000 shares on 08/29/2025 for $3,456,384 is disclosed, indicating recent insider liquidity activity. For investors, this filing documents insider selling but contains no new operational or financial information about the company itself.
TL;DR: Form 144 appears complete for Rule 144 disposition; includes disclosure of acquisition, payment type, and recent related sales.
The notice specifies acquisition type as a restricted stock lapse and payment as equity compensation, satisfying material disclosure elements required for a Rule 144 sale notice. Broker details and aggregate market value are provided, and the filer signs the customary representation regarding material adverse information and potential trading plans. There are no indications of procedural deficiencies within the submitted fields. This is a standard compliance filing documenting intended insider sales rather than a governance event.